Comments
Loading...

Ultragenyx Pharmaceutical

RARENASDAQ
Logo brought to you by Benzinga Data
$57.70
-0.79-1.35%
At Close: -
$57.70
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed

Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock, Earnings Estimates, EPS, And Revenue

Ultragenyx Pharmaceutical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Oct 31
EPS Estimate
$-1.430
Quarterly Revenue Estimate
$135.9M
Annual Revenue
(as of Jun 30)
$481.3M

Analyze the earnings history of Ultragenyx Pharmaceutical using advanced sorting and filters.

Data brought to you by Benzinga APIs

Ultragenyx Pharmaceutical (RARE) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Jun 20242024-08-01$-1.52$-1.7211.6 %
Mar 20242024-05-02$-2.03$-1.76-15.3 %
Dec 20232024-02-15$-1.52$-1.626.17 %
Sep 20232023-11-02$-2.23$-2.06-8.25 %

Ultragenyx Pharmaceutical (RARE) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Jun 20242024-08-01$147.03M$123.18M19.4 %
Mar 20242024-05-02$108.83M$116.17M-6.32 %
Dec 20232024-02-15$127.39M$119.38M6.71 %
Sep 20232023-11-02$98.05M$110.02M-10.9 %

FAQ

Q

When is Ultragenyx Pharmaceutical (NASDAQ:RARE) reporting earnings?

A

Ultragenyx Pharmaceutical (RARE) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 1, 2024 for Q2.

Q

What were the latest earnings per share (EPS) for Ultragenyx Pharmaceutical (NASDAQ:RARE)?

A

The Actual EPS was $-1.52, which beat the estimate of $-1.72.

Q

What were Ultragenyx Pharmaceutical’s (NASDAQ:RARE) revenues?

A

The Actual Revenue was $147M, which beat the estimate of $123.2M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch